PSA levels by age chart: normal range in your 40s, 50s, 60s and 70s

Quick answer: PSA rises with age because the prostate grows: in healthy men with no sign of prostate cancer, the upper limit (95th percentile) climbs from 2.5 ng/mL in the 40s to 6.5 ng/mL in the 70s, about 3.2% a year at age 60. A normal PSA is not a clean bill of health, though: in the Prostate Cancer Prevention Trial, 15.2% of men whose PSA never went above 4.0 ng/mL had cancer on biopsy.

Add PSA to a men's hormone checkHormone Focus includes PSA for men with testosterone, estradiol and SHBG, $124 a test plus $25 shipping.

See Hormone Focus

PSA levels by age: chart with screening guidance

Oesterling's team found PSA tracks prostate size (correlation 0.55) as well as age (0.43), and rises by about 0.04 ng/mL a year in a healthy 60-year-old. ng/mL and µg/L are the same number. For a typical younger man, the AUA guideline cites a median PSA of 0.68 ng/mL at 45 to 49 in the Swedish Malmö cohort.

What the protein is and what raises or lowers it is covered on the main PSA guide. This page is about reading the number against your age.

Cancer odds at each PSA level

In the trial, every man had a biopsy at the end whatever his PSA, so the chart shows how common cancer is at each level, including slow cancers that may never have caused harm. Of the 449 cancers found, 14.9% were high grade (Gleason 7 or more), and the high-grade share rose from 12.5% of cancers at a PSA of 0.5 or less to 25.0% at 3.1 to 4.0. The lesson for age charts: being under your age limit lowers the odds but does not remove them.

A second data point from the AUA guideline: in the Malmö cohort, men aged 45 to 49 in the top tenth of PSA (1.6 ng/mL or more) accounted for nearly half of prostate cancer deaths over the next 25 to 30 years, while men below the median had a 0.85% risk of metastasis within 25 years. A baseline PSA in your 40s mostly helps decide how often to test later.

Screening by age: the shared decision

The US Preventive Services Task Force estimates that screening men aged 55 to 69 prevents about 1.3 prostate cancer deaths per 1,000 men screened over roughly 13 years, and about 3 cases of metastatic cancer per 1,000. The harms are false positives, biopsies, overdiagnosis and treatment side effects such as incontinence and erectile problems. It recommends against screening from 70 and has an update in progress. The AUA's 2023 guideline is more active: shared decision-making, a baseline between 45 and 50, earlier for higher-risk men, and screening every 2 to 4 years from 50 to 69 using online risk calculators.

Questions worth taking to that conversation: your family history, your ancestry, any earlier PSA results, how you would feel about a biopsy, and what you would do with a borderline result.

Worked examples

A 47-year-old with PSA 1.8 ng/mL. Under the 2.5 age limit, but above the 1.6 ng/mL top-tenth mark for men 45 to 49 in the Malmö data. Not a diagnosis; a reason to agree a closer testing schedule with a doctor.

A 58-year-old with 3.2 ng/mL. Under both 4.0 and the 3.5 limit for his age. In the prevention trial, 26.9% of older men with a PSA of 3.1 to 4.0 had cancer on biopsy, so the trend matters: repeat at the same lab and compare with past results.

A 64-year-old with 6.0 ng/mL. Above the 4.5 limit for 60 to 69 and above 4.0. MedlinePlus describes the usual next steps: a repeat PSA, often within 3 months, a free PSA test, a prostate MRI and, if it stays high, a biopsy. Talk to your doctor promptly.

A 73-year-old with 5.9 ng/mL and no symptoms. Inside the 6.5 limit for 70 to 79. The USPSTF recommends against routine screening at this age, so it is worth asking a doctor whether further testing would change anything.

Getting an accurate PSA

• Avoid ejaculation for 24 hours (MedlinePlus) and vigorous cycling for 2 days (NCI) before the test.
• Wait after a urinary infection or a prostate or bladder procedure; ask your doctor how long.
• Tell your doctor about finasteride or dutasteride, which lower PSA.
• Retest with the same lab and method; ARUP notes results from different PSA methods cannot be used interchangeably.

How to test PSA at home

PSA is not on Longevity Essentials, Heart & Metabolic, Thyroid Focus or GLP Optimization.

SiPhox does not include a doctor review, so share any PSA result with your own clinician. Men on testosterone can see what else to monitor in our TRT blood test guide, where testosterone and PSA are read together, and compare broader kits in our at-home blood test for men guide.

A note on home samples: SiPhox's partner lab tests capillary blood collected from the upper arm. SiPhox says its results show a 95% to 99% correlation with venous draws in its own quarterly comparisons against Labcorp and Quest, but it has not published a study of the EasyDraw device, and results come without an included doctor review. If a result would change a treatment decision, confirm it with a venous test through your doctor.

Hormone Focus

$124 + $25 shipping per test

14 biomarkers per test

Sex hormones for men and women, including PSA for men and progesterone for women.

Check price

Ultimate 360

$249 + $25 shipping per test

62 biomarkers per test

Everything on the four core panels plus iron studies, B12 and folate, GGT and PSA.

Check price

Track PSA with your hormonesHormone Focus: PSA, testosterone, estradiol and SHBG from one upper-arm draw. HSA and FSA cards accepted.

Check SiPhox price

Frequently asked questions